MERRILL, A.E., A. SARUKHANOV, Pavel KREJČÍ, B. IDONI, N. CAMACHO, K.D. ESTRADA, K.M. LYONS, H. DEIXLER, H. ROBINSON, D. CHITAYAT, C.J. CURRY, R.S. LACHMAN, W.R. WILCOX a D. KRAKOW. Bent Bone Dysplasia-FGFR2 type, a Distinct Skeletal Disorder, Has Deficient Canonical FGF Signaling. The American Journal of Human Genetics. Chicago: University of Chicago Press, 2012, roč. 90, č. 3, s. 550-557. ISSN 0002-9297. Dostupné z: https://dx.doi.org/10.1016/j.ajhg.2012.02.005. |
Další formáty:
BibTeX
LaTeX
RIS
@article{980985, author = {Merrill, A.E. and Sarukhanov, A. and Krejčí, Pavel and Idoni, B. and Camacho, N. and Estrada, K.D. and Lyons, K.M. and Deixler, H. and Robinson, H. and Chitayat, D. and Curry, C.J. and Lachman, R.S. and Wilcox, W.R. and Krakow, D.}, article_location = {Chicago}, article_number = {3}, doi = {http://dx.doi.org/10.1016/j.ajhg.2012.02.005}, keywords = {APERT-SYNDROME; LADD SYNDROME; GROWTH; MUTATIONS; RECEPTOR-2; ACTIVATION; INDUCTION; CROUZON; MOUSE; DISRUPTION}, language = {eng}, issn = {0002-9297}, journal = {The American Journal of Human Genetics}, title = {Bent Bone Dysplasia-FGFR2 type, a Distinct Skeletal Disorder, Has Deficient Canonical FGF Signaling}, volume = {90}, year = {2012} }
TY - JOUR ID - 980985 AU - Merrill, A.E. - Sarukhanov, A. - Krejčí, Pavel - Idoni, B. - Camacho, N. - Estrada, K.D. - Lyons, K.M. - Deixler, H. - Robinson, H. - Chitayat, D. - Curry, C.J. - Lachman, R.S. - Wilcox, W.R. - Krakow, D. PY - 2012 TI - Bent Bone Dysplasia-FGFR2 type, a Distinct Skeletal Disorder, Has Deficient Canonical FGF Signaling JF - The American Journal of Human Genetics VL - 90 IS - 3 SP - 550-557 EP - 550-557 PB - University of Chicago Press SN - 00029297 KW - APERT-SYNDROME KW - LADD SYNDROME KW - GROWTH KW - MUTATIONS KW - RECEPTOR-2 KW - ACTIVATION KW - INDUCTION KW - CROUZON KW - MOUSE KW - DISRUPTION N2 - Fibroblast growth factor receptor 2 (FGFR2) is a crucial regulator of bone formation during embryonic development. Both gain and loss-of-function studies in mice have shown that FGFR2 maintains a critical balance between the proliferation and differentiation of osteoprogenitor cells. We have identified de novo FGFR2 mutations in a sporadically occurring perinatal lethal skeletal dysplasia characterized by poor mineralization of the calvarium, craniosynostosis, dysmorphic facial features, prenatal teeth, hypoplastic pubis and clavicles, osteopenia, and bent long bones. Histological analysis of the long bones revealed that the growth plate contained smaller hypertrophic chondrocytes and a thickened hypercellular periosteum. Four unrelated affected individuals were found to be heterozygous for missense mutations that introduce a polar amino acid into the hydrophobic transmembrane domain of FGFR2. Using diseased chondrocytes and a cell-based assay, we determined that these mutations selectively reduced plasma-membrane levels of FGFR2 and markedly diminished the receptor's responsiveness to extracellular FGF. All together, these clinical and molecular findings are separate from previously characterized FGFR2 disorders and represent a distinct skeletal dysplasia. ER -
MERRILL, A.E., A. SARUKHANOV, Pavel KREJČÍ, B. IDONI, N. CAMACHO, K.D. ESTRADA, K.M. LYONS, H. DEIXLER, H. ROBINSON, D. CHITAYAT, C.J. CURRY, R.S. LACHMAN, W.R. WILCOX a D. KRAKOW. Bent Bone Dysplasia-FGFR2 type, a Distinct Skeletal Disorder, Has Deficient Canonical FGF Signaling. \textit{The American Journal of Human Genetics}. Chicago: University of Chicago Press, 2012, roč.~90, č.~3, s.~550-557. ISSN~0002-9297. Dostupné z: https://dx.doi.org/10.1016/j.ajhg.2012.02.005.
|